Questions? Call 800-624-6242 About | Ordering | New Menu | Items in cart [0] SEARCH

PAPERBACK price:$31.75 add to cart Rights & Permissions Free PDF Access Sign in to download PDF book and chapters Free Resources PDF SUMMARY Display this book on your site! Related Titles The Domestic and International Impacts of the 2009-H1N1 Influenza A Pandemic:Global Challenges, Global Solutions: Workshop Summary The Threat of Pandemic Influenza: Are We Ready? Workshop Summary Other Related Titles Antivirals for Pandemic Influenza: Guidance on Developing a Distribution and Dispensing Program (2008) Board on Population Health and Public Health Practice (BPH) Citation Manager Export the bibliographic data for this book in your chosen format Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web. Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book. Reference Finder Paste in your own text to find books that relate to your topic. Citation Manager . "Appendix C: Meeting One Agenda." Antivirals for Pandemic Influenza: Guidance on Developing a Distribution and Dispensing Program. Washington, DC: The National Academies Press, 2008. Please select a format: Page 107   E-mail Share on facebook Facebook Share on delicious Delicious Share on stumbleupon Stumble Share on twitter Twitter More Sharing ServicesMore The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. Appendix C Meeting One Agenda Committee on Implementation of Antiviral Medication Strategies for an Influenza Pandemic Meeting 1 December 3–4, 2007 National Academy of Sciences Building 2101 Constitution Avenue, NW Washington, DC AGENDA December 3, 2007 Auditorium 1:00 pm Welcome, Committee Introductions, and Opening Comments June Osborn Committee Chair Background 1:15 pm Charge to the Committee Guidance on Use of Antiviral Drugs and Planning Assumptions Benjamin Schwartz Senior Science Advisor National Vaccine Program Office Department of Health and Human Services 1:45 pm Committee Questions Page 107 Front Matter (R1-R10) Summary (1-10) 1 Introduction (11-18) 2 Antiviral Effectiveness, Safety, and Supply (19-38) 3 Ethics, Decision Making, and Communication (39-52) 4 Who Should Get Antivirals and Where? (53-86) References (87-92) Appendix A: Summary of Lessons Learned from Other Mass Distribution Events (93-98) Appendix B: State Plans (99-106) Appendix C: Meeting One Agenda (107-112) Appendix D: Meeting Two Agenda (113-116) Appendix E: Committee Member Biographies (117-122)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 107
Antivirals for Pandemic Influenza: Guidance on Developing a Distribution and Dispensing Program Appendix C Meeting One Agenda Committee on Implementation of Antiviral Medication Strategies for an Influenza Pandemic Meeting 1 December 3–4, 2007 National Academy of Sciences Building 2101 Constitution Avenue, NW Washington, DC AGENDA December 3, 2007 Auditorium 1:00 pm Welcome, Committee Introductions, and Opening Comments June Osborn Committee Chair Background 1:15 pm Charge to the Committee Guidance on Use of Antiviral Drugs and Planning Assumptions Benjamin Schwartz Senior Science Advisor National Vaccine Program Office Department of Health and Human Services 1:45 pm Committee Questions

OCR for page 108
Antivirals for Pandemic Influenza: Guidance on Developing a Distribution and Dispensing Program 2:15 pm Primer on Antiviral Drug Effectiveness and Resistance Fred Hayden World Health Organization Professor of Internal Medicine and Pathology Department of Medicine Division of Infectious Diseases and International Health University of Virginia Health System Infectious Diseases Society of America 2:45 pm Committee Questions 3:00 pm Antiviral Drug Stockpiling and Distribution Planning Anita Patel Health Scientist Lockheed Martin Information Technology Contractor assigned to Division of Strategic National Stockpile Coordinating Office of Terrorism Preparedness and Emergency Response Centers for Disease Control and Prevention 3:15 pm Committee Questions 3:30 pm Legal Issues in an Influenza Pandemic James G. Hodge Associate Professor Johns Hopkins Bloomberg School of Public Health Executive Director and Principal Investigator Centers for Law and the Public’s Health: A Collaborative Core Faculty, Johns Hopkins Berman Institute of Bioethics 3:45 pm Committee Questions 4:00 pm Break Panel 1: Diagnosing Influenza 4:15 pm Diagnosis in Children John Bradley Director of the Division of Infectious Diseases Children’s Hospital, San Diego American Academy of Pediatrics Infectious Diseases Society of America

OCR for page 109
Antivirals for Pandemic Influenza: Guidance on Developing a Distribution and Dispensing Program 4:30 pm Diagnosis in Adults Andrew Pavia George and Esther Gross Presidential Professor Chief of the Division of Pediatric Infectious Diseases University of Utah Health Sciences Center and Primary Children’s of Utah Infectious Diseases Society of America Member of the Institute of Medicine Committee 4:45 pm Other Diagnostic Issues Marie Griffin Professor of Preventive Medicine Professor of Medicine Vanderbilt University School of Medicine 5:00 pm Infection Control in the Waiting Room Richard Clover Dean School of Public Health and Information Sciences University of Louisville 5:15 pm Committee Questions and Discussion with Panel 5:45 pm Adjourn December 4, 2007 Lecture Room 8:00 am Welcome June Osborn Committee Chair Panel 2: Treating Cases and Providing Post-Exposure Prophylaxis to Their Household Contacts 8:15 am Federal, State, and Local Laws Regarding Prescribing and Dispensing Stephen W. Schondelmeyer Chair Department of Pharmaceutical Care Health Care Systems Professor of Pharmaceutical Economics Century Mortar Club Endowed Chair in Pharmaceutical Management University of Minnesota

OCR for page 110
Antivirals for Pandemic Influenza: Guidance on Developing a Distribution and Dispensing Program 8:30 am Federal Regulatory Perspective Barbara A. Styrt Medical Officer Division of Antiviral Drug Products Office of Antimicrobial Products Office of New Drugs Center for Drug Evaluation and Research Food and Drug Administration 8:45 am Role of Pharmacies Catherine M. Polley Vice President Pharmacy Services Food Marketing Institute 9:00 am Other Issues Related to Dispensing Prophylaxis Tammy Robertson Operations Manager, Fedex Custom Critical 9:15 am Committee Questions and Discussion with Panel 9:45 am Break Panel 3: State and Local Planning 10:00 am State Planning (overview, considerations, and examples) Donald E. Williamson Health Officer Alabama State Department of Health 10:30 am Local Planning (overview, considerations, and examples) Jane Zucker Assistant Commissioner Bureau of Immunization New York City Department of Health and Mental Hygiene Paul Biedrzycki Director Disease Control and Prevention City of Milwaukee Health Department

OCR for page 111
Antivirals for Pandemic Influenza: Guidance on Developing a Distribution and Dispensing Program   Junie Delizo Director Emergency Preparedness Rockland County (NY) Department of Health 11:30 am Committee Questions and Discussion with Panel 12:00 pm Lunch Panel 4: Outbreak Prophylaxis of Health Care Workers 1:00 pm Hospital-Based Prophylaxis Allison McGeer Microbiologist, Infectious Disease Consultant Mount Sinai Hospital Toronto, Ontario Professor Departments of Laboratory Medicine and Pathobiology Department of Public Health Sciences University of Toronto Stephen R. Pitts Attending Physician, Emory Crawford Long Hospital Emergency Department Associate Professor Department of Emergency Medicine Emory University School of Medicine on sabbatical as AcademyHealth Fellow National Center for Health Statistics 1:45 pm Prophylaxis at Outpatient Sites Douglas Campos-Outcalt Clinical Professor and Associate Chair Department of Family and Community Medicine University of Arizona College of Medicine American Academy of Family Physicians 2:00 pm Long-Term Care Facilities Janice Zalen Director of Special Programs American Health Care Association

OCR for page 112
Antivirals for Pandemic Influenza: Guidance on Developing a Distribution and Dispensing Program 2:30 pm Health Care Worker Labor Issues Katherine Cox Health Policy Analyst American Federation of State, County and Municipal Employees International 2:45 pm Committee Questions and Discussion with Panel 3:00 pm Break Panel 5: Outbreak Prophylaxis in Emergency Service Organizations (fire, police, emergency medical services) 3:15 pm Emergency Medical Services (EMS) Kathy Robinson Program Advisor National Association of State EMS Officials 3:30 pm Fire John Delaney Captain Fire Department Arlington County, VA 4:00 pm Committee Questions and Discussion with Panel 4:30 pm Adjourn